Neovasc signs licensing deal with Penn Medicine and Gorman Cardiovascular Research Group

Image: Tiara is Neovasc’s minimally invasive transcatheter device for patients who experience severe mitral regurgitation. Photo: courtesy of judith hakze / FreeImages.